Corrigendum to ‘B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis’ [J Hepatol (2022) doi: 10.1016/j.jhepr.2022.100460] by Maaike Biewenga, Sebastiaan Heidt, Manon Vergunst, Camiel J.M. Marijnissen, Rob A. de Man, Annemiek A. van der Eijk, Adriaan J. van der Meer, Leendert A. Trouw, Bart van Hoek

Get full text

Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival by Vincenzo Ronca, Alessandro Parente, Ellina Lytvyak, Bettina E. Hansen, Gideon Hirschfield, Alan Bonder, Maryam Ebadi, Saleh Elwir, Mohamad Alsaed, Piotr Milkiewicz, Maciej K. Janik, Hanns-Ulrich Marschall, Maria Antonella Burza, Cumali Efe, Ali Rıza Calışkan, Murat Harputluoglu, Gökhan Kabaçam, Débora Terrabuio, Fernanda de Quadros Onofrio, Nazia Selzner, Albert Parés, Laura Llovet, Murat Akyıldız, Cigdem Arikan, Mihael P. Manns, Richard Taubert, Anna-Lena Weber, Thomas D. Schiano, Brandy Haydel, Piotr Czubkowski, Piotr Socha, Natalia Ołdak, Nobuhisa Akamatsu, Atsushi Tanaka, Cynthia Levy, Eric F. Martin, Aparna Goel, Mai Sedki, Irena Jankowska, Toru Ikegami, Maria Rodriguez, Martina Sterneck, Marcial Sebode, Christoph Schramm, Maria Francesca Donato, Francesca Colapietro, Ansgar Lohse, Raul J. Andrade, Vilas R. Patwardhan, Bart van Hoek, Maaike Biewenga, Andreas E. Kremer, Yoshihide Ueda, Mark Deneau, Mark Pedersen, Marlyn J. Mayo, Annarosa Floreani, Patrizia Burra, Maria Francesca Secchi, Benedetta Terziroli Beretta-Piccoli, Marco Sciveres, Giuseppe Maggiore, Syed-Mohammed Jafri, Dominique Debray, Muriel Girard, Florence Lacaille, Michael Heneghan, Andrew L. Mason, Ye Oo, Aldo J. Montano-Loza

Get full text